These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22472645)

  • 1. Effects of donor characteristics and ex vivo expansion on canine mesenchymal stem cell properties: implications for MSC-based therapies.
    Volk SW; Wang Y; Hankenson KD
    Cell Transplant; 2012; 21(10):2189-200. PubMed ID: 22472645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Instant stem cell therapy: characterization and concentration of human mesenchymal stem cells in vitro.
    Kasten P; Beyen I; Egermann M; Suda AJ; Moghaddam AA; Zimmermann G; Luginbühl R
    Eur Cell Mater; 2008 Oct; 16():47-55. PubMed ID: 18946860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human embryonic stem cell-derived mesenchymal stroma cells (hES-MSCs) engraft in vivo and support hematopoiesis without suppressing immune function: implications for off-the shelf ES-MSC therapies.
    Li O; Tormin A; Sundberg B; Hyllner J; Le Blanc K; Scheding S
    PLoS One; 2013; 8(1):e55319. PubMed ID: 23383153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells for tissue engineering and regenerative medicine.
    Tae SK; Lee SH; Park JS; Im GI
    Biomed Mater; 2006 Jun; 1(2):63-71. PubMed ID: 18460758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Porcine Versus Human Mesenchymal Stromal Cells From Three Distinct Donor Locations for Cytotherapy.
    Schweizer R; Waldner M; Oksuz S; Zhang W; Komatsu C; Plock JA; Gorantla VS; Solari MG; Kokai L; Marra KG; Rubin JP
    Front Immunol; 2020; 11():826. PubMed ID: 32435248
    [No Abstract]   [Full Text] [Related]  

  • 6. Co-culture of the bone and bone marrow: a novel way to obtain mesenchymal stem cells with enhanced osteogenic ability for fracture healing in SD rats.
    Zhu C; Sha M; Jiang H; Lin J; Lin W; Li W; Chen X; Huang G; Ding Z
    J Orthop Surg Res; 2019 Sep; 14(1):293. PubMed ID: 31481070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of Donor's Age on Immunomodulatory Properties of Canine Adipose Tissue-Derived Mesenchymal Stem Cells.
    Taguchi T; Borjesson DL; Osmond C; Griffon DJ
    Stem Cells Dev; 2019 Dec; 28(23):1562-1571. PubMed ID: 31588862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Mesenchymal Stem Cells (MSCs) in Veterinary Medicine and Their Use in Musculoskeletal Disorders.
    Prządka P; Buczak K; Frejlich E; Gąsior L; Suliga K; Kiełbowicz Z
    Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix-mediated retention of in vitro osteogenic differentiation potential and in vivo bone-forming capacity by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Kirker-Head C; Abrahamson L; Gronowicz G; Volloch V; Kaplan DL
    J Biomed Mater Res A; 2006 Dec; 79(3):464-75. PubMed ID: 16752403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regenerative medicine laboratory: facilitating stem cell therapy for equine disease.
    Borjesson DL; Peroni JF
    Clin Lab Med; 2011 Mar; 31(1):109-23. PubMed ID: 21295725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix-mediated retention of adipogenic differentiation potential by human adult bone marrow-derived mesenchymal stem cells during ex vivo expansion.
    Mauney JR; Volloch V; Kaplan DL
    Biomaterials; 2005 Nov; 26(31):6167-75. PubMed ID: 15913765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in Endocrine, Metabolic and Immune Disorders: Mesenchymal Stem Cells (MSCs) and Engineered Scaffolds.
    Cantore S; Crincoli V; Boccaccio A; Uva AE; Fiorentino M; Monno G; Bollero P; Derla C; Fabiano F; Ballini A; Santacroce L
    Endocr Metab Immune Disord Drug Targets; 2018; 18(5):466-469. PubMed ID: 29692270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The angiogenic properties of mesenchymal stem/stromal cells and their therapeutic potential.
    Watt SM; Gullo F; van der Garde M; Markeson D; Camicia R; Khoo CP; Zwaginga JJ
    Br Med Bull; 2013; 108(1):25-53. PubMed ID: 24152971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury.
    Takahashi A; Nakajima H; Uchida K; Takeura N; Honjoh K; Watanabe S; Kitade M; Kokubo Y; Johnson WEB; Matsumine A
    Cell Transplant; 2018 Jul; 27(7):1126-1139. PubMed ID: 29947256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Proliferation and Osteogenic Differentiation Potential of Rat Mandibular and Femoral Bone Marrow Mesenchymal Stem Cells In Vitro.
    Li C; Wang F; Zhang R; Qiao P; Liu H
    Stem Cells Dev; 2020 Jun; 29(11):728-736. PubMed ID: 32122257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Same or not the same? Comparison of adipose tissue-derived versus bone marrow-derived mesenchymal stem and stromal cells.
    Strioga M; Viswanathan S; Darinskas A; Slaby O; Michalek J
    Stem Cells Dev; 2012 Sep; 21(14):2724-52. PubMed ID: 22468918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparative Study of Biological Characteristics and Transcriptome Profiles of Mesenchymal Stem Cells from Different Canine Tissues.
    Zhan XS; El-Ashram S; Luo DZ; Luo HN; Wang BY; Chen SF; Bai YS; Chen ZS; Liu CY; Ji HQ
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30934541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Age-related biological characteristics of human bone marrow mesenchymal stem cells from different age donors].
    Huang K; Zhou DH; Huang SL; Liang SH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1049-53. PubMed ID: 16403278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guided bone regeneration in pig calvarial bone defects using autologous mesenchymal stem/progenitor cells - a comparison of different tissue sources.
    Stockmann P; Park J; von Wilmowsky C; Nkenke E; Felszeghy E; Dehner JF; Schmitt C; Tudor C; Schlegel KA
    J Craniomaxillofac Surg; 2012 Jun; 40(4):310-20. PubMed ID: 21723141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
    Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
    Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.